Navidea Biopharmaceuticals


Navidea Biopharmaceuticals Stock Quote
$2.88 $0.05 1.8%
Price as of September 22, 2020, 4:15 p.m. EDT View Interactive NAVB Charts

Neoprobe Corporation is a biomedical company which is engaged in the development and commercialization of innovative surgical and diagnostic products that enhance patient care by meeting the critical decision making needs of physicians.

Interactive Chart

News & Analysis: Navidea Biopharmaceuticals


3 Stocks to Get on Your Watchlist

A once "golden" stock, a promising medical diagnostics company, and a sneaky play in the oil and gas sector top this week's must-adds to your Watchlist.

The 5 Most Misdiagnosed Diseases

Many of us implicitly trust our physicians to be right, but that isn't always the case. Here are the five most commonly misdiagnosed diseases and what might be done to help prevent misdiagnoses in the future.